Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection

Liver Transplantation

Volumn 15, Issue 9, 2009, Pages 1003-1006

  Stock, Peter G ^a   Fung, John ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; MIXED INFECTION; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; SCORING SYSTEM; SURVIVAL RATE; TREATMENT CONTRAINDICATION; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; HEALTH STATUS INDICATORS; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 70350551808     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21840     Document Type: Editorial

References (7)

1. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001;32:492-497. (Pubitemid 32173638)
2. Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl 2006;12:801-807.
3. Ragni M, Belle S, Im K, Neff G, Roland M, Stock P, et al. Survival in HIV-infected liver transplant recipients. Paper presented at: 10th Conference on Retroviruses and Opportunistic Infections; February 2003; Boston, MA.
4. Duclos-Vallée JC, Féray C, Sebagh M, Teicher E, Roque-Afonso AM, Roche B, et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008;47:407-417. (Pubitemid 351280708)
5. Miro JM, Aguero F, Laguno M, Tuset M, Cervera C, Moreno A, et al. Liver transplantation in HIV/hepatitis co-infection. J HIV Ther 2007;12:24-35.
6. Ragni M, Eghtesad B, Schlesinger K, Dvorchik I, Fung J. Pre-transplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl 2005;11:1425-1430. (Pubitemid 43071593)
7. Murillas J, Rimola A, Laguno M, et al. MELD score is the best prognostic factor in HIV-1-infected patients with end-stage liver disease: a prospective cohort study. Liver Transpl 2009;15:1133-1141.